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Pathogen infections are recognized by the immune system, which consists of 
two types of responses: an innate immune response that recognizes pathogen-
associated molecular patterns (PAMPs) and an antigen-specific adaptive immune 
response. In both responses, there are several activated cells of the immune system, 
which play a key role in establishing the environment of cytokines, thus directing 
their differentiation either suppressing or promoting the immune response. This 
immune response is crucial against pathogen infections. In this chapter, we will 
describe the crucial role played by different families of cytokines during activation 
of the immune system to eliminate infectious pathogens.
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1. Introduction
The innate and adaptive immune responses are key factors in the control of 
infections or chronic diseases. The balance between these two systems is mainly 
orchestrated by cytokines [1]. Cytokines are low-molecular-weight proteins that 
contribute to the chemical language that regulates the development and repair of 
tissues, hematopoiesis, inflammation, etc., through the transduction of signals 
mediated by binding to cellular receptors. Cytokines can act on their target cells 
in an autocrine, paracrine, and/or endocrine fashion to induce systemic and/or 
localized immune responses. In addition, cytokines have pleiotropic activity, that 
is, they act on different target cells, as well as affect the function of other cytokines 
in an additive, synergistic, or antagonistic manner [2, 3]. Cytokines can be secreted 
by immune cells, but they can also be produced by a wide variety of cells in response 
to infection or can be produced or released from cells in response to cellular dam-
age when cellular integrity is compromised. Acting through a series of conserved 
signaling pathways that program transcriptional pathways by controlling many bio-
logical processes, such as cell growth, cell differentiation, apoptosis, development, 
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and survival, can also reprogram cells in the local tissue environment to improve 
certain types of immune responses. Therefore, cytokines are critical mediators of 
communication for the immune system and are essential for host defense against 
pathogens [4].
2. Cytokines
The cytokine pattern that is released from the cell depends primarily on the 
nature of the antigenic stimulus and the type of cell being stimulated. Cytokines 
compromise leukocytes to respond to a microbial stimulus. Cytokines can be classi-
fied into six groups: (1) L1 superfamily, (2) TNF superfamily, (3) IL-17 family, (4) 
IL-6 superfamily, (5) type I superfamily, and (6) type II superfamily [5].
2.1 IL-1 superfamily
More than any other cytokine family, the interleukin (IL)-1 family of ligands 
and receptors is primarily associated with acute and chronic inflammation. The 
cytosolic segment of each IL-1 receptor family member contains the Toll/interleu-
kin-1 receptor (TIR) domain. This domain is also present in each Toll-like receptor 
(TLR), which responds to microbial products and viruses [6]. Since TIR domains 
are functional for both receptor families, responses to the IL-1 family are funda-
mental to the innate immunity [7].
2.1.1 IL-1 family of cytokines and innate immune system
There are 11 members of IL-1 family of cytokines (IL-1α, IL-1β, IL-1Ra, IL-18, 
IL-33, IL-36α, IL-36β, IL-36γ, IL-36Ra IL-37, and IL-38) and 10 members of the 
IL-1 family of receptors (IL-1R1 to ILR10) [8, 9]. More than any other cytokine 
family, the IL-1 family members are closely linked to damaging inflammation; 
however, the same members also work to increase nonspecific resistance to infec-
tion and the development of an immune response to a foreign antigen [10].
The numerous biological properties of the IL-1 family are nonspecific. The 
importance of IL-1 family members to the innate response became evident upon the 
discovery that the cytoplasmic domain of the IL-1 receptor type 1 (IL-1R1) is also 
found in the Toll protein of the fruit fly. The functional domain of the cytoplasmic 
component of IL-1R1 is termed the TIR domain. Thus, fundamental inflammatory 
responses such as the induction of cyclooxygenase type 2 (COX-2), production of 
multiple cytokines and chemokines, increased the expression of adhesion molecules, 
or synthesis of nitric oxide (NO) are indistinguishable responses of both IL-1 and 
TLR ligands [11]. Both TLR and IL-1 families nonspecifically augment antigen 
recognition and activate lymphocyte function. The lymphocyte-activating function 
of IL-1 was first described in 1979 and is now considered a fundamental property of 
the acquired immune response. IL-1β is the most studied member of the IL-1 family 
due to its role in mediating auto-inflammatory diseases. Unquestionably, IL-1β 
evolved to assist host defense against infection, and this landmark study established 
how a low dose of recombinant IL-1β protects mice against lethal bacterial infection 
in the absence of neutrophils. Although we now accept the concept that cytokines 
like IL-1β served millions of years of evolution to protect the host, in the antibiotic 
and antiviral therapies era of today, we view cytokines as the cause of disease due 
to acute or chronic inflammation [12]. IL-1β has emerged as a therapeutic target 
for an expanding number of systemic and local inflammatory conditions called 
auto-inflammatory diseases. The neutralization of IL-1β results in a rapid and 
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sustained reduction in disease severity. Treatment for autoimmune diseases often 
includes immunosuppressive drugs, whereas neutralization of IL-1β is mostly 
anti- inflammatory. The auto-inflammatory diseases are caused due to gain-of-
function mutations for caspase-1 activity, and common ailments, such as gout, type 
2 diabetes, heart failure, recurrent pericarditis, rheumatoid arthritis, and smoldering 
myeloma, respond to the IL-1β neutralization [7]. IL-1 family also includes member 
that suppress inflammation, specifically within the IL-1 family, such as the IL-1 
receptor antagonist (IL-1Ra), IL-36 receptor antagonist (IL-36Ra), and IL-37. In 
addition, the IL-1 family member IL-38, the last member of the IL-1 family of 
cytokines to be studied, nonspecifically suppresses inflammation and limits the 
innate immunity [12].
2.1.2 IL-1 receptor family
There are 10 members of the IL-1 family receptors. IL-1R1 binds IL-1α, IL-1β, 
and IL-1Ra and IL-R1 binds either IL-1β or IL-1α. IL-1R2 is a decoy receptor for 
IL-1β. IL-1R2 lacks a cytoplasmic domain and exists not only as an integral mem-
brane protein but also in a soluble form. The term soluble is meant to denote the 
extracellular domain only. The soluble domain of IL-1R2 binds IL-1β in the extracel-
lular space and neutralizes IL-1β. The neutralization of IL-1β by soluble IL-1R2 is 
greatly enhanced by forming a complex with IL-1R3. IL-1R3 is the co-receptor for 
IL-1α, IL-1β, IL-33, IL-36a, IL-36β, and IL-36γ. IL-1R3 exists as an integral mem-
brane receptor or in a soluble receptor form. The inflammation and infection drive 
liver to increase the synthesis and levels of soluble IL-1R3 in the circulation [13].
2.2 TNF superfamily
Tumor necrosis factor superfamily (TNFSF) is a group of cytokines composed 
of 19 ligands and 29 receptors [14]. This family plays a pivotal role in immunity, 
inflammation and controlling cell cycle, proliferation, differentiation, and apop-
tosis [15]. TNFSF receptors can be divided into two different groups depending 
on the presence or absence of the intracellular death domain (DD) [16]. Signaling 
via the death domain demands the involvement of adapter proteins Fas-associated 
death domain (FADD) and TNF receptor-associated proteins (TRADD), leading to 
the activation of caspases that result in apoptotic death of a cell. The second group 
of TNFSF receptor signals acts only via adapter proteins termed tumor necrosis 
factor receptor-associated proteins (TRAFs). The DD containing receptors may 
use the pathway [17]. The functional activity of TNFSF receptors depends on the 
cellular context and the balance between pro- and antiapoptotic factors inside the 
cell and in the environment. Mostly, the TNFSF members are revealed on the cells 
of immune system and play a notable function in maintaining the equilibrium of 
T-cell–mediated immune responses by arranging direct signals required for the full 
activation of effector pool and survival of memory T cells. The TNFSF members 
are necessary in the development of pathogenesis of many T-cell–mediated autoim-
mune diseases, such as asthma, diabetes, and arthritis [16].
2.2.1 TNF-α
Tumor necrosis factor (TNF)-α is classified as homotrimeric transmembrane 
protein with a prominent role in systemic inflammation. Macrophages/monocytes 
are capable to produce TNF-α in the acute phase of inflammation, and this cytokine 
drives a wide range of signaling events within cells, leading to necrosis or apoptosis 
[17]. The TNF superfamily incorporates receptor activator of nuclear factor κB 
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(RANK), cluster of differentiation (CD)-40, CD27, and FAS receptor. This protein 
was discovered in the circulation of animals subsequent to the stimulation of their 
reticuloendothelial system and lipopolysaccharide (LPS) challenge. This protein has 
been found to provoke a rapid necrotic regression of certain forms of tumors [16].
2.2.2 Biological roles of TNF-α
Several biological functions are ascribed to the TNF-α, and for this reason, the 
mechanism of action is somewhat complex. Because this protein confers resistance 
to certain types of infections and in parallel causes pathological complications, 
it carries out contradictory roles. This may be connected to the varied signaling 
pathways that are activated. TNF-α modulates several therapeutic roles within 
the body, such as immunostimulation, resistance to infection agents, resistance to 
tumors, sleep regulation, and embryonic development [17]. On the other hand, 
parasitic, bacterial, and viral infections become more pathogenic or fatal due to 
TNF circulation. The major role of TNF is explicated as mediator in resistance 
against infections. Moreover, it was postulated that TNF plays a pathological role 
in several autoimmune diseases such as graft versus host rejection or rheumatoid 
arthritis. In addition, TNF exhibits antimalignant cell cytotoxicity in association 
with interferon. High concentrations of TNF-α are toxic to the host. The enhance-
ment in the therapeutic index by decreasing toxicity or by increasing effectiveness 
is indeed needed. This may be possible through the mutations that reduce systemic 
cytotoxicity and increase TNF’s effectiveness in selectively eliminating tumor cells. 
TNF-α is also implicated in physiological sleep regulation. TNF-related proteins 
such as receptor activator for nuclear factor κB ligand (RANKL) are required for 
osteoclast differentiation necessary for bone resorption [16].
2.3 IL-17 family
IL-17 is a pro-inflammatory cytokine. There are six family known members of 
IL-17. Also, we have just a little information of its biological functions, being the 
IL-17A and the IL-17F described recently [18]. IL-17–related cytokines play key 
roles in defense against extracellular pathogen, and their participation in the devel-
opment of autoimmune diseases has drawn significant attention. Moreover, some of 
these molecules are involved in the amplification and perpetuation of pathological 
processes in many inflammatory diseases. However, the same cytokines can exert 
anti-inflammatory effects in specific settings, as well as play a key role in the control 
of immune homeostasis [19, 20].
2.4 IL-6 superfamily
IL-6 family is a group of cytokines and colony-stimulating factors (CSFs) 
that include IL-6, IL-27, IL-31, IL-35, ciliary neurotrophic factor (CNTF), leu-
kemia inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin (CT)-1, and 
cardiotrophin-like cytokine (CLC), among others [16, 17]. This cytokine family 
binds to its receptor, allowing a binding with the gp130 subunit [21, 22]. This bind-
ing allows dimerization of the subunit homogeneously or heterogeneously (either 
with the same subunit or cytokine receptor), creating a receptor complex. This 
complex allows associated proteins phosphorylation, such as Janus kinases (JAK) 
type 1, 2, and tyrosine kinase (TYK) 2, among others, which triggers a signaling 
pathway through phosphorylation toward types of signal transducer and activa-
tor of transcription (STAT) 1–6, forming another dimerization, homogeneous or 
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heterogeneous with other STATs, that gets into the nucleus, recognizing promoter 
regions and initiating the regulation of the expression of specific genes [22, 23].
In IL-6 family, there are soluble receptors that have different signaling pathways, 
which are mostly of inhibitory function. Although they bind to the same cytokine 
and to the same subunit, they transmit different signaling called trans-signaling. It 
is observed that these soluble receptors prolong its effect and have action on cells 
where cytokine emerges effect; namely, all cells reactive to IL-6 will have the soluble 
receptor of IL-6 (IL-6Rs) function [21, 24]. Main functions of this IL-6 family 
cytokines are inflammation proteins production in acute phase, B cell differentia-
tion into antibody-forming plasma cell, T cell modulator, development of Th17, and 
hematopoiesis, among other functions [24–26].
2.5 Type I superfamily
Type I cytokine family, also known as hematopoietins, is made up of several 
types of cytokines, including IL-2, IL-3, IL-4, IL-6, IL-7, IL-9, IL-12, IL-15, IL-21, 
and granulocyte-macrophage colony-stimulating factor (GM-CSF), among others. 
This group of cytokines has α, β, and γ chain in common. IL-2, -4, -7, -9, -13, -15, 
and -21 have in common the γ chain (also known as IL2Rγ or CD132) for activa-
tion of JAK1/JAK3 and downstream STAT 1–5. While IL-3, -5, and GM-CSF share 
the common β chain (CSF2RB/CD131) for activation of the JAK/STAT pathway 
through interactions with JAK2 [3, 27], α chains do not activate signaling pathways 
but increase the binding affinity between the cytokine and β and γ subunit [3, 28], 
helping receptor specificity for gene expression [27]. While the receptor is more 
complex, there is more affinity of the cytokines of the receptor, which increases the 
signaling [27, 29]. The specificity of the receptor is conferred by α and β subunit, 
that in combination with γ subunit provides different stimulations. This means that 
the same cytokines can have different effects on the cell, depending on the receptor 
complexity; for example, IL-2 binds to its γ chain receptor (CD132) and β chain 
(IL-2Rβ), forming an intermediate affinity dimer, or also the binding of α chain 
(IL-2Rα), generating a high affinity. Phosphorylating tyrosine residues in JAKs, 
which lead to signaling to STAT5, prolonging and increasing its effect unlike the 
intermediate affinity [30]. Among the main functions of this cytokine family are 
the growth and differentiation of precursor leukocytes, as well as being modulators 
and initiators of the inflammatory response [3, 27].
2.6 Type II superfamily
The type II superfamily is composed of the subfamilies of interferons (IFNs) 
and IL-10. IFN family has the characteristic of inducing antiviral response in both 
hematopoietic and structural cells, serving as an essential mediator of cross talk 
between the immune system and host physiology during viral infections [3, 29]. 
This family is divided into three types INFs families: types I, II, and III.
Type I IFNs family is mainly composed of IFN-α and -β. IFN-α is expressed in 
leukocytes and IFN-β in fibroblasts, dendritic, and plasmacytoid cells. These IFNs 
have signaling pathways through JAK1 and TYK2 to phosphorylate STAT1 and 
STAT2 [29, 31]. These IFNs have a powerful proinflammatory effect and an antiviral 
response in immune and nonhematopoietic cells, as well as they can synergize with 
type II interferon (i.e., IFNγ) to potentiate Th1 lineage commitment by T-helper 
cells and cytotoxic activity by CD8+ cells [3].
Type II IFNs family is composed only by IFN-γ, which is produced by active 
CD4+ and CD8+ T cells, NK cells, and macrophages by stimulation of IL-12, IL-18, 
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and TNF-α [3, 29, 32]. IFN-γ has signaling pathways with STAT1 through JAK1 and 
JAK2 [29]. IFN-γ is mediator of interaction of innate and adaptive immune cells. 
IFN-γ promotes B-cell differentiation toward plasma cells immunoglobulin (Ig)-G-
production. Also, IFN-γ induces phagocytosis through the antimicrobial potential 
activation on macrophages. IFN-γ increases the expression of major histocompat-
ibility complex (MHC) I and II, molecules in antigen-presenting cells, promotes 
complement activation, and increases cytotoxic activity of T cells and differentia-
tion Th1 cell differentiation for the clearance of infectious pathogens [3, 32].
Type III INFs family is composed by IFNλ-1 (IL-29), IFNλ-2 (IL-28A), and 
IFNλ-3 (IL-28B) [3, 29, 32]. IFNλ-1 and -2 regulate IFN expression [3], being 
structurally and functionally like them by sharing beta chain but with less intensity 
[32]. IFNλ-3 induces antiviral response in cells through STAT1 and STAT2 [3, 33].
IL-10 is a potent pro-inflammatory cytokine, which is produced by different 
cells such as monocytes, macrophages, Th2, and Treg cells. The IL-10 performs 
its functions through the activation of the STAT1, STAT3, PI3K, and p38 mitogen-
activated protein kinases (MAPK) pathways. Among its most important functions 
are the suppression of Th1 cytokines, the classically activated/M1 macrophage 
inflammatory gene expression, and the presentation of antigen [3].
3. Cytokine profile in bacterial infections
During a bacterial infection in the host, a nonspecific and immediate immune 
response is initiated to eliminate the pathogen, and this nonspecific response 
involves the recruitment of neutrophils, macrophages and dendritic cells, comple-
ment activation, and cytokine production [34]. This response can inhibit or limit 
microbial growth but also can cause host damage, and so it is necessary to keep this 
response under control; to achieve this, the host performs some strategies, including 
the production of cytokines. These molecules play an important role in intercellular 
communication and coordinate the innate and adaptive response [35].
In microbial infections, the pattern-recognition receptors (PRRs) recognize 
several PAMPs [36] such as DNA, double-stranded RNA (dsRNA), single-stranded 
RNA (ssRNA), and 5′-triphosphate RNA, as well as lipoproteins, surface glycopro-
teins, membrane components peptidoglycans, lipoteichoic acid (LTA), lipopoly-
saccharide (LPS), and glycosyl-phosphatidyl-inositol. The recognition of PAMPs 
by PRRs leads to the activation of NF-κB and/or MAPK [37] to produce several 
cytokines such as IL-1α, IL-1β, TNFα, IFN-γ, IL-12, and IL-18, being TNF-α and 
IL-1β the main inflammatory mediators, since they play an important role in medi-
ating the local response through cellular activation. The inflammatory response 
that occurs in the presence of an infection consists of several protective effector 
mechanisms that promote the microbicidal functions and in turn stimulate adaptive 
immunity, which contributes to reduce the damage of the tissues [38] (Figure 1).
IL-1β is a cytokine that is inducible through the activation of PRRs such as TLRs, 
by microbial products or damaged cell factors [39], once the recognition of the 
ligands through the receptors activates the downstream signaling pathways activat-
ing the NF-κB, activator protein (AP)-1, MAPK, and type I IFNs pathways, resulting 
in an upregulation of inflammatory mediators, as well as chemotactic factors [40]. 
IL-1β is synthesized as a precursor peptide (pro-IL-1β) that is cut to generate its 
mature form (mIL-1β); this process involves caspase 1, and the proenzyme (procas-
pase-1) requires it to be cut by the inflammasome, which is a multimeric cytosolic 
protein complex, composed of NLR family-pyrin domain containing 3 (NALP3) and 
the adapter protein containing CARD (ASC) and caspase-1; once IL-1β is cut by this 
complex, it binds to the IL-1R1 receptor, thus initiating the signaling that induces 
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the expression of adhesion molecules in the endothelial cells and promotes the 
recruitment of neutrophils to the site of inflammation, as well as of the monocytes. 
It also has a potent stimulatory effect on phagocytosis, and it produces a chemotactic 
effect on leukocytes and induces the production of other inflammatory mediators 
of the lipid type, as well as other cytokines [41]. In vivo studies show that IL-1β is an 
important cytokine for the host defense against some microbial pathogens. During 
infection with Staphylococcus aureus, it was shown that the interaction of IL-1β with 
its receptor IL-1R plays an important role in the recruitment of neutrophils, suggest-
ing that IL-1β is crucial for host defense against S. aureus and this can be transpolar 
to infections induced by other microorganisms [42].
Another cytokine that accompanies the IL-1β response is TNF-α, and this cyto-
kine is produced initially during endotoxemia, as well as in response to some micro-
bial products. TNF-α shares with IL-6 an important inflammatory property, that is, 
the induction of acute phase reactant protein by the liver [43]. In vivo studies show 
that TNF-α plays an important role in mediating clearance through the recruitment 
of neutrophils and macrophages to the site of infection after a bacterial intraperito-
neal challenge [44], followed by an increase in the expression of COX-2, as well as 
inducible nitric oxide synthase (iNOS), which leads to the production of prostaglan-
din (PG)-E2 and NO to eradicate the pathogen and recover homeostasis [45].
During bacterial infections, the IL-17 is another important cytokine produced. 
IL-17A plays an important role in the defense of the host against extracellular bacte-
ria. The cells that are characterized mainly by producing IL-17 are a subpopulation 
of CD4+ T cells, and their differentiation and maturation are favored by a mixture 
of cytokines, including transforming growth factor (TGF)-β and IL-6, IL-21 and 
TGF-β, or IL-1, IL-6, and IL-23 [46, 47]. The protective capacity of IL-17A against 
infectious agents can be mediated through several mechanisms, among these is the 
ability of IL-17A in the barrier surfaces to induce the production of inflammatory 
Figure 1. 
Cytokines profile in bacterial infections. In response to bacterial infection, the IL-1 family cytokines, such 
as IL-1β, potently induces the expression of adhesion molecules in the endothelial cells and promotes the 
recruitment of neutrophils to the site of inflammation. TNF-α plays an important role through the recruitment 
of neutrophils and macrophages, besides inducing the expression of proinflammatory mediators to the site of 
infection. Th17 cells produce IL-17A, which induces the production of inflammatory mediators such as IL-1β, 
IL-6, GM-CSF, G-CSF, and TNF-α, as well as adhesion molecules. IL-18 also promotes the secretion of other 
proinflammatory cytokines like TNF-α, IL-1β, IL-8, and GM-CSF and consequently enhancement, migration, 
and activation of neutrophils during infections.
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mediators such as IL-1β, IL-6, GM-CSF, granulocyte colony stimulating factor 
(G-CSF), and TNF-α, as well as adhesion molecules. IL-17A also induces the pro-
duction of chemotactic factors, such as chemokine-(C-C motif)-ligand (CCL)-2, 
CCL7, CXCL1, CXCL2, CXCL5, and CXCL8, responsible for recruiting neutrophils 
and monocytes, as well as the CCL20 that is involved in the recruitment of dendritic 
cells, with the aim of eliminating the extracellular pathogen [48]. In vivo and 
in vitro studies show that signaling through TLR4 is the main mechanism by which 
IL-17 is induced in response to Klebsiella pneumoniae infection, which induces an 
upregulation of granulopoietic cytokines involved in the recruitment of neutrophils 
[49]. In mice lacking the IL-17 receptor, the recruitment of neutrophils decreased, 
the bacterial load increased, and survival was compromised. Whereas overexpres-
sion of IL-17 through an adenovirus, resulted in the production of cytokines mainly, 
macrophage inflammatory protein (MIP)-2, G-CSF, TNF-α, and IL-1β, increasing 
the recruitment of neutrophils, bacterial clearance and finally survival after infec-
tion with K. pneumoniae [50]. And finally, PGE2 increases the expansion of Th17 
cells in an IL-1β dependent manner, thus favoring the recruitment of these cells 
to the site of damage. In vitro studies show that Th17 cells in the presence of PGE2 
increase the production of CCL20, thus favoring the control of infection [51].
IL-18 also promotes the secretion of other proinflammatory cytokines like 
TNF-α, IL-1β, IL-8, and GM-CSF and consequently enhancement, migration, and 
activation of neutrophils during infections. IL-18 increases the cytotoxic activ-
ity and proliferation of CD8+ T and NK cells, as well as promotes the secretion 
of inflammatory mediators of the type TNF-α, IL-1β, IL-8, and GM-CSF, which 
will activate neutrophils, thus increasing their migration [38]. During a bacterial 
infection, IL-18 plays an important role, since it induces IFN-γ production of NK 
cells [52]. The IFN-γ that is produced activates macrophages and produces cytokines 
that induce antimicrobial pathways against intracellular and extracellular pathogens 
[53]. Infection with strains of lactobacillus nonpathogenic and with streptococcus 
pyogenes induces the expression of IL-1β, IL-6, TNF-α, IL-12, IL-18, and IFN-γ, 
suggesting that this type of bacterial strains induces Th1 type cytokines [54].
4. Cytokine profile in fungal infections
As well as the response to bacteria, the response against fungi also requires 
coordination of the innate and adaptive immune system. The innate immune system 
performs its effect through the cells that have the phagocytic and antigen presenting 
function. These cells include neutrophils, macrophages, and dendritic cells [55]. 
The recognition of pathogens by the immune system involves four class of PRRs: 
TLRs, C-type lectin receptors (CLRs), nucleotide-binding oligomerization domain-
like (NOD-like) receptors (NLRs), and retinoic acid-inducible gene I (RIG-I) like 
receptors (RLRs) [56]. The CLRs, especially Dectin-1 and 2, play an important role 
in the pathogen recognition from Candida spp.; this is because the cell wall is made 
up of mannoproteins with O-glycosylated oligosaccharide and N-glycosylated poly-
saccharide moieties, with an inner layer of chitin and β (1, 3) and β (1, 6) glucans 
are recognized and initiate a downstream signaling through these receptors, which 
leads to activation of the transcription factor NF-κB and other signaling pathways 
that induce the production of pro-inflammatory cytokines such as IL-6, IL-1β, and 
IL-23 that induce the Th17 cytokines [57] (Figure 2).
The recognition of fungi by phagocytic cells occurs mainly through the detec-
tion of cell wall components such as mannan, β-glucan, phosphocholine, β-1,6 
glucan, and even internal components such as DNA can be recognized [58, 59]. The 
recruitment and activation of phagocytic cells are mediated through the induction 
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of proinflammatory cytokines, chemokines, and complement components. Fungi 
are killed by oxidative and nonoxidative mechanisms and antimicrobial peptides. 
These activities are influenced by the action of cytokines such as IFN-γ [59]. This 
cytokine produced mainly by T and NK cells stimulates the migration, adherence, 
and phagocytosis of neutrophils and macrophages and production of opsonizing 
antibodies and maintains a Th1 response as a protective response against fungi. 
It also induces a classical activation of macrophages that is important to stop the 
growth of intracellular fungal pathogens [60]. The Th1 response occurs through 
the release of proinflammatory cytokines IFN-γ, TNF-α, and GM-CSF, increasing 
the permeability in the tissue, as well as the phagocytic cells at the site of infection 
to efficiently clean the infection [61] (Figure 2).
Another important cytokine in immunity against fungi is IL-12, and this 
cytokine is considered the main cytokine that induces IFN-γ production. IL-12 is 
produced by monocytes, macrophages, and dendritic cells, in response to micro-
bial products, and acts on NK and T cells to induce IFN-γ. On the other hand, the 
late secretion of IL-12 in the lymph nodes induces naive T cells to produce IFN-γ 
and therefore amounting a Th1 response is promoted [62]. The ability of IFN-γ to 
increase the production of IL-12 forms a positive feedback during the inflammatory 
process and the Th1 response, and this interferon in turn activates monocytes and 
macrophages to induce the production of IL-12 [63] (Figure 2). Studies in Il12p35−/− 
and IFN-γ−/− mice show an increase in susceptibility to infections with Candida 
albicans, and this suggests that IL-12 and the Th1 responses play an important 
role in controlling Candida infection [64]. On the other hand, neutrophils kill the 
extracellular and intracellular fungi through effector mechanism that includes the 
production of reactive oxygen and nitrogen species, as well as the release of hydro-
lytic enzymes and their granules containing antimicrobial peptides [65].
IL-23 is a member of the IL-12 family and plays a central role in the expansion of 
Th17 cells as well as their function, composed of a p19 and p40 subunit that shares 
it with IL-12 [66, 67]. IL-23 is produced primarily by dendritic cells, the binding 
of β-glucan to Dectin-1 activates the syk-CARD-9 signaling pathway leading to the 
production of IL-23, which promotes the Th17 response, through the differentiation 
Figure 2. 
Cytokines profile in fungal infections. The PRRs recognize fungal PAMPs and initiate a downstream signaling, 
which leads to the activation of the NF-κB and other signaling pathways inducing the production of cytokines 
such as IL-6, IL-1β, IL-12, TNF-α, GM-CSF, IFN-γ, and IL-23. These cytokines induce the differentiation 
of Th1 and Th17 immune responses against fungi infection, stimulating the migration, adherence, and 
phagocytosis of neutrophils and macrophages.
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of naïve CD4+ T cells into Th17 cells and the release of IL-17A, IL-17F and IL-22 in 
response to infections caused by mucosal fungi [68]. These cytokines in conjunc-
tion with IL-23 have various functions in the body from a proinflammatory, anti-
inflammatory, or regulatory activity, which depends on the type of microorganism, 
the site of infection, and the immunological status of the host (Figure 2). In vivo 
studies have shown that mice deficient of the IL-17 receptor (IL-17RA−/−) cannot 
limit systemic candidiasis, as well as oropharyngeal candidiasis, being more sus-
ceptible to developing mucocutaneous candidiasis, suggesting that the Th17 lineage 
strongly acts through IL-17, regulating the expansion, recruitment, and migration 
of neutrophils, as well as CXC-chemokines and antimicrobial proteins such as 
β-defensin 3 [66, 69].
5. Cytokine profile in viral infections
In viral infections, the cytokines are implicated to establish an antiviral state as 
the unspecific first line of defense and virus-specific response. This process initiates 
through recognition of viral molecules by PRRs, which can be found as transmem-
brane receptors or in different intracellular compartment. The receptor undergoes a 
structural change, activating a route of signalization in the cytoplasm that end with 
the activation of cytoplasmic transcription factors that translocate into the nuclei to 
promote the expression of different cytokines. Depending of the virus and the type 
of cell, the type of cytokine produced may vary [70, 71].
5.1 Pattern recognition receptors versus virus
Viruses can infect virtually all cells of an organism. Epithelial, endothelial, fibro-
blasts, neurons, as well as innate and adaptive immune cells can be infected. PRRs are 
present in both nonhematopoietic origin cell and immune cells. Some PRRs recognize 
viral proteins, but other can detect viral single or double RNA or DNA. In human, 
there are 10 TLRs distributed in plasmatic membrane and endosome membranes. Of 
them, TLR-2 and TLR-4 can detect viral surface glycoprotein before the viral penetra-
tion. Others like TLR-3, TLR-8, and TLR-9 sense different types of viral nucleic acids 
in endosomes during virus entering. TLR-8 senses genomic ssRNA, TLR-3 senses 
dsRNA, and TLR-9 detects nonmethylated CpG viral DNA [72, 73]. Another type of 
receptors that sense viral RNA are the RNA helicases receptors like RIG-I and mela-
noma differentiation-associated gene 5 (MDA5) [71, 74]. These receptors have been 
demonstrated to detect viral dsRNA. This dsRNA can be genomic or an intermediate 
form during replication, which is formed, virtually, for all virus of single or double 
RNA during viral replication. However, there is evidence that some dsRNA replicative 
intermediators can translocate to endosomes where TLR can sense and trigger the 
signalization way [75].
5.2 Cytokines produced in viral infections
There are many cytokines with distinct functions. All of them are molecules 
with less than 20 KDa and can be pleiotropic or redundant, and also, they can 
synergize or antagonize each other. However, all of them are produced to ensure 
the virus elimination through the regulation of the immune response against the 
virus [76]. The process includes detection of the pathogen, signal to neighbor cells, 
activation and differentiation of innate immune cells, production of adhesion 
molecules on endothelial cell for extravasation of immune circulating cell, chemo-
tactic molecules to attract cell to the infection foci, increase of phagocytosis, and 
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activation of adaptive cells to specifically eliminate infected cells and extracellular 
virus [77].
Cytokine network against viruses starts with some cytokines produced by 
virus-infected cells (Figure 3). Epithelial cell can produce IFN, IL-8, IL-6, IL-1, 
GM-CSF [78, 79], TNFα [80], IL-18 [81], IL-12 [82], IL-2 [83], and IL-23 [84, 85]. 
The role of these cytokines is varied, IFN induces an antiviral state, and IL-8 is 
a potent inflammatory attracting phagocyte cell to the site of infection. IL-1 can 
promote apoptosis, and it is proinflammatory and chemotactic to neutrophils. 
GM-CSF is a hematopoietic grow factor that recruits various immune cells to host 
defense [76, 86]. Moreover, in the infection course, varies cytokines are also pro-
duced by innate and adaptive cell that can also be infected or activated. In filovirus 
infection, IL-1β, IL-5, IL-8, and IL-18, as well as varies chemokines like MIP-1α and 
β, monocyte chemoattractant protein 1 (MCP-1), and IFN-γ–inducible protein 10 
(IP10) among others are produced [77]. In influenza virus infection, TNF-α, IL-1 
α and β, and IL-6 and IL-8 are produced [87], and hepatitis C virus can promote 
the expression of IL-6, IL-8, MIP-1α, and MIP-1β and IL-1 [88], while rotavirus can 
induce the production of IFN, IL-8, IL-6, IL-1 [89], TNF-α [80], IL-18 [81], IL-12 
[82], IL-2 [83], and IL-23 [84, 85]. Thus, the infected cell can upregulate multiple 
cytokine genes involved in different process as activation of NK, macrophages, and 
dendritic cells. Increasing the production of cytokines that serve as bridge between 
innate and adaptive response. In the inflammation process, virus-infected cells 
produce and secrete proinflammatory cytokines like IL-1, IL-6, IL-8, TNF [70] and 
Figure 3. 
Cytokines profile in viral infections. The immune response against viruses initiates through recognition of viral 
molecules by PRRs. These PRRs can activate a signal system culminating in the activation of transcription 
factors involved in the establishment of an antiviral state and an inflammation process. Cytokine network 
against viruses start with some cytokines produced by virus infected cells, such as IFNs, IL-8, IL-6, IL-1, 
GM-CSF, TNFα, IL-18, IL-12, IL-2 and IL-23, inducing a potent inflammatory response, attracting and 
activating phagocyte cells (e.g. neutrophils, macrophages, dendritic cells), mast cells and NK cells, to the site of 
infection. Furthermore, these cytokines are involved in the induction of an immune response type Th1/TCL with 
the purpose of eliminate infected cells and extracellular virus while cytokines such as IL-4, IL-10, IL-13, IL-37, 
and TGF-β modulate the immune response to a Th2 and Th17 phenotype, which produce immunomodulatory 
and anti-inflammatory actions.
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IFN. These cytokines can be involved in the early defense of the organism. They 
can activate cells present in the site of infection, and they can recruit leukocyte cells 
from circulating system through inflammation process (Figure 3).
5.3 Cytokines’ role in viral infection
IFN is a pleiotropic cytokine produced by virus infection. Although there are 
three types of IFN called type I (α/β), type II (γ) and type III (λ). Type I IFN plays 
an important role in control early viral infections. The role of type I IFN is to inter-
fere with viral replication through activating the expression of antiviral molecules. 
Once IFN is secreted, it can act in autocrine or paracrine (like other cytokines) way, 
interacting with interferon receptor to induce the production of an antiviral state 
in the infected and noninfected neighboring cells, inhibiting different step of viral 
replication [76]. Also, IFN promotes the production of cytokines like IL-12, IL-6, 
IFN-γ, and TNF-α in innate cells including NK cells and macrophages [90]. Another 
function of IFN is to enhance differentiation of dendritic cells [91] and promote the 
antigen presentation [90] to stimulate T and B cells [92], which is redundant with 
the function of the IL-12 and IL-18 [93, 94]. NK cells are activated by synergism 
between type 1 IFNs and IL-12. However, cytokines such as IL-10, IL-6, IL-4, IL-13, 
and TGF-β suppress the actions of IFN, and these cytokines are known for their 
immunomodulatory and anti-inflammatory actions [95].
TNF-α is other pleiotropic cytokine produced by also nonhematopoietic 
infected cells and innate and adaptive immune cells, including macrophages, den-
dritic cells, natural killer, and T and B lymphocytes after being activated [96]. This 
cytokine can activate the production of adhesion molecules in endothelial cells 
and promote the extravasation of neutrophils, monocytes, and others immune 
cells to be attracted to infection foci. TNF also can participate in apoptosis through 
activating caspases. TNF-α, together with IFN-γ, acts on macrophages, induc-
ing the production of superoxide anions and oxygen and nitrogen radicals [97]. 
Macrophages can also produce cytokines such as IL-1, IL-6, IL-23, IL-12, and more 
TNF-α [95].
IL-1 was the first interleukin to be identified and is a pleiotropic cytokine, and it 
acts synergically with IL-6 on the central nervous system, inducing fever by activa-
tion of the hypothalamus-pituitary-adrenal (HPA) axis [98]. This molecule also 
activates mast cells and induces histamine production, acting as a vasodilator, thus 
increases the permeability of the membrane [99]. Also, IL-1 is chemotactic factor 
that induces the passage of neutrophils to the site of infection. This chemotactic 
function is redundant with the action of IL-8, also known as chemokine CXCL8 
[86] also produced by the infected cell. There are cytokines that antagonize these 
functions of IL-1 such as IL-10, IL-4, and IL-13 recognized for their anti-inflamma-
tory actions [100].
Another pleiotropic cytokine is IL-18, first described as “interferon-γ-inducing 
factor” and member of IL-1 family. This interleukin and type I IFN are recognized 
by dendritic cells and trigger a signaling pathway through TRF6 and induce the 
expression of CD11b+ in the surface of the cell [94]. These activated cells can 
express cytokines like IL-12, IL-6, IFN-γ, TNFα, and IFN-α, which also partici-
pates in other hematopoietic cells [101, 102]. IL-18 also participates synergistically 
with interleukin 12 on the activation of NK cells [93], stimulating the expression 
of CD25 and CD69 molecules, promoting their proliferation and cytotoxic capac-
ity, respectively. Once activated, NK cells can induce apoptosis in virus-infected 
cells and produce other cytokines such as IL-12, IL-6, IL-10, IFN-γ, and TNF-α. 
Within the cytokines that block these functions of IL-18 are IL-37, IL-10, and 
TGF-β [103].
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IL-6 is a soluble mediator with a pleiotropic effect on inflammation, immune 
response, and hematopoiesis. IL-6 is an important mediator of fever and of the 
acute phase response, which is redundant with IL-1 and TFN-α and promotes the 
differentiation of cytotoxic T lymphocytes, which induce the death of infected cells 
by osmotic lysis [104]. IL-6 synergistically with IL-23 participates in the differentia-
tion of Th17 [105], through the production of RORγt. Once activated, Th17 induces 
inflammatory response through the expression of cytokines as IL-17 and IL-22. 
IL-6 also promotes the proliferation of B cells by binding to a complex of receptors 
(gp80, CD126, and CD130) [106] and, like IL-21 [107], induces the differentiation 
of plasma cells stimulating the antibody production [108]. However, there exist 
antagonist cytokines like IL-10, IL-13, and TGF-β that inhibit all these functions of 
the IL-6 [103].
IL-12, also known as a T cell-stimulating factor, which together with IFN-γ, pro-
motes differentiation of Th1 cells by activation of T-bet, and these cells can activate 
macrophages through expression of other cytokines like IFN and TNF, amplifying 
the produced immune response [109]. Although, there is evidence that viruses may 
selectively induce IFN production and Th1 differentiation even in the absence of 
IL-12 [110].
IL-2 participates in the differentiation and proliferation of Th2 (redundant with 
IL-4) and Treg cells by the expression of GATA-3 and FOXP3, respectively [111, 
112]. Th2 cells can express IL-4, IL-5, IL-9, and IL-13, which also have pleiotropic 
effects in promoting type 2 effector mechanisms, such as B cells secretion of immu-
noglobulins, eosinophilia, mastocytosis, and M2 macrophage polarization [113]. 
Treg cells regulate the immune response, suppressing T-cell activation [114]. Treg and 
Th2 are known for their immunomodulatory and anti-inflammatory actions [95]. 
Finally, GM-CSF stimulates the generation of dendritic cells and participates in 
polarization of macrophages M1 [115]. Moreover, GM-CSF has also been associated 
with Th2 immunity and therefore M2 polarization. GM-CSF is considered a pleio-
tropic cytokine with inflammatory and anti-inflammatory functions [116].
6. Cytokine profile in parasitic infections
In parasitic infections is difficult to generalize about the mechanisms of anti-
parasitic immunity because there is a great variety of different parasites that have 
different morphology and reside in different locations of tissues and hosts during 
their life cycles [117]. In this section of the chapter, we will talk about the immune 
response against protozoa and helminths, two of the main parasites of medical 
importance for human health.
6.1 Immune system activation by parasitic protozoan infections
Protozoan parasites are much larger and more complex pathogens than viruses 
or bacteria and have developed additional and sophisticated strategies to escape the 
immune attack of the host. Currently, 30% of humans suffer parasitic protozoan 
infections worldwide. Life cycles of protozoans generally involve several stages of 
specific antigenicity, which facilitates their survival and propagation within differ-
ent cells, tissues, and hosts. Frequently, the host fails to eliminate protozoan infec-
tions, which often results in a chronic disease or inapparent infections, in which the 
host continues to act as a reservoir of parasites [118].
The immune defense mechanisms against protozoan parasites frequently 
involve several immune cells such as neutrophils, macrophages, and NK cells that 
mediate the innate response against extracellular protozoan parasites. NK cell and 
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cytokine-activated macrophages are central to the innate response to intracellular 
parasites. Innate cytokine and dendritic cell responses also play a critical role in the 
induction of adaptive immunity [119].
During the initial stage of parasitic protozoan infections, intestinal epithelial 
cells (IECs) bind and recognize PAMPs through PRRs [120] such as TLR-2 and 
TLR-4 [121], which activates NF-κB and leads to the production of proinflamma-
tory cytokines [122], including IL-1β, IL-6, IL-8, IL-12, IFN-γ, and TNF-α [123, 
124], which induces the activation of a Th1 type response [125]. IFN-γ is involved 
in clearance of infection, through the activation of neutrophils and macrophages 
(Figure 4) [126–132]. It has been also shown that IFN-γ-producing CD4+ T cells 
are involved protection in vaccinated mice [133]. Several studies suggest a role for 
IFN-γ in the pathogenesis of parasitic protozoan infections. In both humans and 
animal models, the production of high levels of IFN-γ is associated with resistance 
to infection [134–136], while low levels of IFN-γ are associated with an increased 
susceptibility to infection. Therefore, it is considered highly probable that IFN-γ 
provides protection against infection by activation of neutrophils and/or macro-
phages [125]. The production of reactive oxygen species (ROS) and NO through 
the complex of NADPH oxidase and iNOS, respectively, plays a critical role in the 
elimination of protozoan parasites [131, 132]. In experimental studies, infection 
protection was mediated by IFN-γ from NK T cells (NKT), while TNF-α is produced 
by increased tissue damage [137, 138], together with IL-1 and IL-8 [139] (Figure 4).
On the other hand, the antigenic exposure of protozoan parasites activates a 
Th2-type immune response by the host, inducing the production of anti-inflamma-
tory cytokines such as IL-4, IL-10 [125], IL-5 and IL-13, which try to attenuate the 
Th1 type response characterized also by the INF-γ production, leading to upregula-
tion of Th2 cytokine responses (IL-4, IL-5, and IL-13) and Th17 (IL-17), suppress-
ing the production of Th1 cytokines [140] (Figure 4). In addition, another cytokine 
of anti-inflammatory importance is TGF-β, which acts in a synergistic manner 
to counteract this Th1 type response, activating macrophages which produce 
Figure 4. 
Cytokines profile in parasitic protozoan infections. The immune defense mechanisms against protozoan 
parasites involve several immune cells such as neutrophils, macrophages, NK cells, and CD4+ T cells. These 
cells are capable to produce proinflammatory cytokines, such as IL-1β, IL-6, IL-8, IL-12, IFN-γ, and TNF-α, 
promoting type 1 immune response. Likewise, protozoan parasites activate a Th2-type immune response, 
producing anti-inflammatory cytokines such as IL-4, IL-10, IL-5, and IL-13, suppressing the production of Th1 
cytokines.
15
Cytokine Profiling Plays a Crucial Role in Activating Immune System to Clear Infectious Pathogens
DOI: http://dx.doi.org/10.5772/intechopen.80843
NO, through iNOS, for the elimination of the parasite [138]. Therefore, Th1-type 
cytokine response is characterized mainly by the production of IFN-γ, whereas 
susceptibility to tissue damage by protozoan parasites is critically dependent on a 
Th2-type cytokine response mediated mainly by IL-4.
6.2  Immune system activation by parasitic helminth infection
More than two billion people around the world are infected with helminth para-
sites. Parasitic helminth infections are a major public health problem worldwide due 
to their ability to cause great morbidity and socioeconomic loss [141, 142].
The immune response against helminth parasites is characterized by the induc-
tion of an early Th1-type immune response, with the subsequent predominance 
of a Th2 type immune response, resulting in a mixture of both Th1/Th2 immune 
responses [143, 144], which depend on the CD4+ T cells [145]. The CD4+ T cells 
have a key role in the establishment of the cytokine environment during helminth 
parasite infection, thus directing their differentiation either by suppressing or 
favoring the inflammatory response at the intestinal level, which is crucial for the 
elimination of the parasite [146] (Figure 5).
PAMPs derived from helminth parasites induce the activation and matura-
tion of dendritic cells [147, 148], promoting the development of the Th1 immune 
response [149], which results in a significant increase of Th1 cytokines such as IL-12 
[150–152], INF-γ [149–153], IL-1β [152, 154], and TNF-α [150–152, 155] (Figure 5). 
However, in recent years, several studies have shown that this immune response of 
Th1 type favors infection by helminth parasites. On the one hand, IL-12 and INF-γ 
are two important cytokines against infection by helminth parasites, since they 
participate in the polarization of the Th1 type immune response [149–151, 153]. 
However, exogenous IL-12 is capable of suppressing intestinal mastocytosis, delay-
ing the parasite expulsion, and increasing the parasite burden at the muscular level 
[156]. INF-γ induces the expression of iNOS, activates transcription factors such as 
NF-κB [157], and regulates the production of pro-inflammatory cytokines such as 
TNF-α [158]. Studies have shown that TNF-α is a cytokine that is produced during 
Figure 5. 
Cytokines profile in parasitic helminth infection. The immune response against helminth parasites is 
characterized by the induction of an early Th1 type immune response, which results in a significant increase 
of Th1 cytokines such as IL-12, INF-γ, IL-1β, and TNF-α. Then, there is a subsequent predominance of a Th2 
type immune response characterized by the release of IL-4, IL-5, IL-10, and IL-13 favoring helminth parasites 
expulsion.
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intestinal infection by helminth parasites [150, 151, 159], which is necessary in the 
protection against the parasite through the Th2 immune response [160]. However, 
several studies have associated the production of TNF-α with the development of 
intestinal pathology during infection by helminth parasites [155, 161, 162]. One of 
the effects of TNF-α is the iNOS expression and consequently the NO production 
[163–165]. Helminth parasite antigens are capable to induce the expression of iNOS, 
with the subsequent production of NO [166], which acts mainly as an effector mol-
ecule against both extracellular and intracellular parasites [167]. Studies in iNOS 
knockout mice infected with helminth parasites, showed a reduction in the expres-
sion of Th2 cytokines (IL-4, IL-5), a reduced humoral response (IgG and IgE), with 
a decrease in mastocytosis. However, no significant difference was observed in the 
helminth parasite expulsion, although iNOS knockout mice showed a decrease in 
intestinal pathology compared to wild-type animals. These results suggest that NO 
is not required for the helminth parasite expulsion, but its production is responsible 
for the intestinal pathology [155, 168]. With respect to IL-1β, it is well known that 
it participates in the intestinal inflammatory response in the helminth parasites 
infection, observing high levels during intestinal infection. However, until now, the 
role of IL-1β is not well understood [159].
With respect to the Th2 type immune response, in vitro studies have shown that 
helminth parasite antigens are capable of dendritic cells activating, inducing the 
synthesis of Th2 cytokines such as IL-4, IL-5, IL-10, and IL-13 [147, 149, 153, 169]. 
Likewise, studies in in vivo models have shown that helminth parasites infection is 
a significant increase in the synthesis of IL-4, IL-5, IL-10, and IL-13 [150, 151, 159, 
170] (Figure 5). IL-10 may suppress antigen presentation by dendritic cells and 
inhibition of IL-12 secretion. In addition, helminth parasite antigens increased both 
IL-4 and IL-10 production derived from Th2 cells with a decrease in INF-γ produc-
tion, polarizing the immune response to a strong Th2 cellular immune response, 
protective and responsible for the helminth parasite expulsion [143]. IL-10 is a Th2 
cytokine, which is necessary for a successful intestinal immune response. This is 
because the absence or decrease of IL-10 causes a significant delay in the helminth 
parasite expulsion and an increase in the parasite burden [171]. IL-4 and IL-13 
induce muscle cells hypercontractility of the jejunum and intestinal mastocytosis, 
promoting the helminth parasite expulsion [161, 172]. In IL-4/IL-13 mice deficient, 
a reduction in the helminth parasite expulsion, mastocytosis, and development of 
intestinal pathology was observed [161, 162, 173, 174]. Therefore, these studies sug-
gest that IL-4 and IL-13 can regulate the induction of the protective Th2 immune 
response and intestinal inflammation, both associated with the helminth parasite 
expulsion [162]. During the Th2 immune response, the cytokines such as IL-4, 
IL-5, and IL-13 stimulate IgE synthesis [175], inducing mast cell and eosinophil 
hyperplasia [176], triggering immediate hypersensitivity reactions, and promot-
ing the helminth parasite expulsion from the intestine [177]. However, mast cells 
and eosinophils are involved in tissue damage, thus promoting the inflammatory 
response. It suggests that the protective role of the Th2 type immune response is not 
sufficient facing the challenge against helminth parasite infections, as it contributes 
to the development of immunopathology [178] (Figure 5).
7. Conclusion
Although cytokines are produced with the purpose of modulating the immune 
response against infections caused by microorganisms, such as bacteria, fungi, 
viruses, and parasites, there is evidence that these microorganisms can induce cyto-
kine production with bad prognostic to host recovery. In this sense, overproduction 
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of inflammatory cytokines may be responsible for the severe damage observed in 
many microorganism infections. For this reason, a better understanding over the 
cytokine balance related to diseases by microorganisms is required to avoid severe 
damage against the organism caused by overreaction of the immune system.
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